Catalyst
Slingshot members are tracking this event:
PMDA Accepts Athersys' (ATHX) Ischemic Stroke Therapy MultiStem for Pivotal Trial in Japan
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| ATHX |
|
|
Healios KK |
|
|
|
Slingshot Insights Explained
Catalyst Date
Occurred on:
Sep 12, 2016
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Pharmaceutical And Medical Devices Agency, Clinical Trial Notification, Multistem, Ischemic Stroke, Hlcm051, Pivotal Trial, Confirmatory Trial
